Patient experience with non-invasive prenatal testing (NIPT) as a primary screen for aneuploidy in the Netherlands

BACKGROUND: Non-invasive prenatal testing (NIPT) as a screening method for trisomy 21 and other chromosomal abnormalities has been adopted widely across the globe. However, while many clinical validation studies have been performed, less is known regarding the patient experience with NIPT. This stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Kristalijn, Syanni A., White, Karen, Eerbeek, Deanna, Kostenko, Emilia, Grati, Francesca Romana, Bilardo, Caterina M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585792/
https://www.ncbi.nlm.nih.gov/pubmed/36266611
http://dx.doi.org/10.1186/s12884-022-05110-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585792/
https://www.ncbi.nlm.nih.gov/pubmed/36266611
http://dx.doi.org/10.1186/s12884-022-05110-2

Ejemplares similares